Idorsia Ltd (IDRSF) Q2 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-07-30 18:32:21 ET
Idorsia Ltd (IDRSF)
Q2 2025 Earnings Conference Call
July 30 2025, 08:00 AM ET
Company Participants
Andrew Jones - Senior VP, Head of Corporate Communications & Investor Relations
Arno Groenewoud - Executive VP & CFO
Michael Moye - President/GM of Idorsia US
Srishti Gupta - CEO & Executive Director
Presentation
Operator
Good day and thank you for standing by. Welcome to the Idorsia Half Year 2025 Financial Results Webcast and Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded....
Read the full article on Seeking Alpha
For further details see:
Idorsia Ltd (IDRSF) Q2 2025 Earnings Call Transcript
Idorsia Ltd Registered Shares
NASDAQ: IDRSF
IDRSF Trading
0.0% G/L:
$5.16 Last:
1,502 Volume:
$5.16 Open:
IDRSF Latest News
January 05, 2026 11:45:00 am
Idorsia's daridorexant in women during menopausal transition age with insomnia
December 10, 2025 01:00:00 am
New Hypertension publication underscores aprocitentan's potential in managing hypertension patients with CKD
November 10, 2025 11:45:00 am
Idorsia's aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
November 05, 2025 11:45:00 am
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific Sessions
